ARRIVO BIOVENTURES LLC
Our expertise is drug development. Whether we are developing a reformulated product, a new chemical entity, or a biologic, the team at Arrivo BioVentures has expertise in identifying regulatory strategies to expedite the path to approval and the efficient implementation of the clinical programs themselves. We coordinate with the FDA (and other regulatory bodies) early and often to gain agreement on the development programs for our products, minimizing surprises and speeding implementation.
ARRIVO BIOVENTURES LLC
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical Device
Founded:
2015-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.arrivobio.com
Total Employee:
11+
Status:
Active
Contact:
(919)460-9500
Email Addresses:
[email protected]
Total Funding:
94.25 M USD
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Adgero Biopharmaceuticals
Adgero Biopharmaceuticals, Inc. is a privately-held biopharmaceutical company focused on building a robust pipeline
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Invo Bioscience
INVO Bioscience is a medical device company founded by Claude Ranoux, MD, MS, a noted expert in the field of reproductive health,
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Solas BioVentures
Solas BioVentures investment in Series B - Arrivo BioVentures LLC
Rex Health Ventures
Rex Health Ventures investment in Series B - Arrivo BioVentures LLC
Orlando Health Ventures
Orlando Health Ventures investment in Series B - Arrivo BioVentures LLC
Solas BioVentures
Solas BioVentures investment in Series A - Arrivo BioVentures LLC
Rex Health Ventures
Rex Health Ventures investment in Series A - Arrivo BioVentures LLC
Jazz Pharmaceuticals
Jazz Pharmaceuticals investment in Series A - Arrivo BioVentures LLC
Official Site Inspections
http://www.arrivobio.com Semrush global rank: 9.12 M Semrush visits lastest month: 445
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Arrivo BioVentures LLC"
About Us - ARRIVO Bioventures
He also directed the Intercontinental Neuroscience Medical Organization for 4 years. Joel has engaged with governments, regulators, payers, scientific organizations, physicians, educators …See details»
Arrivo BioVentures LLC - Crunchbase Company Profile & Funding
Our expertise is drug development. Whether we are developing a reformulated product, a new chemical entity, or a biologic, the team at Arrivo BioVentures has expertise in identifying …See details»
Arrivo BioVentures LLC - LinkedIn
Arrivo BioVentures LLC Research Services Morrisville, North Carolina 1,027 followers The Strength of a Trusted PartnershipSee details»
Arrivo BioVentures - PitchBook
Www.arrivobio.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 3000 RDU Center Drive; Suite 130; Morrisville, NC 27560-9731; United StatesSee details»
Arrivo BioVentures - Overview, News & Similar companies
Jan 3, 2024 ArrivoBio Raises $45M in Series B Financing to Advance Pipeline MORRISVILLE, N.C.--(BUSINESS WIRE)--Arrivo BioVentures today announced the closing of an …See details»
Series B - Arrivo BioVentures LLC - 2023-11-29 - Crunchbase
Nov 29, 2023 Organization Name . Arrivo BioVentures LLC . Announced Date Nov 29, 2023; Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . obfuscated. ...See details»
Arrivo BioVentures LLC | North Carolina Biotech Center
Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions.See details»
What You Need to Know About Arrivo BioVentures - BioSpace
January 9, 2017 By Mark Terry, BioSpace.com Breaking News Staff. Arrivo BioVentures, based in Morrisville, N.C., is focused on accelerating biologics and small molecules through clinical …See details»
Arrivo BioVentures - Company Profile - Tracxn
Aug 15, 2024 Arrivo BioVentures - Developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. Raised a total funding of $94.2M …See details»
Arrivo BioVentures LLC | VentureRadar
"Arrivo BioVentures, LLC is a privately held biopharmaceutical development company focused on identifying biologics and small molecules to improve patient care.See details»
Arrivo BioVentures Company Profile - Office Locations ... - Craft
Arrivo BioVentures has 1 employees at their 1 location and $49 m in total funding,. See insights on Arrivo BioVentures including office locations, competitors, revenue, financials, executives, …See details»
Arrivo BioVentures LLC Overview - Salary.com
Discover essential details about Arrivo BioVentures LLC, including address, contact, and journey of our company's evolution.See details»
Arrivo - Crunchbase Company Profile & Funding
Organization. Arrivo . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. Arrivo builds technology based on the hyperloop architecture that …See details»
Arrivo BioVentures Emerges from Stealth Mode with a Robust …
Information, visit www.arrivobio.com Media Contact Scott Yates OnPoint Communications Group LLC (for Arrivo) 919-649-6621 [email protected] . Title: Microsoft Word - Arrivo …See details»
Arrivo BioVentures Emerges from Stealth Mode with a Robust …
Dec 13, 2021 For more information, visit www.arrivobio.com. Contacts. Media Contact Scott Yates OnPoint Communications Group LLC (for Arrivo) 919-649-6621 …See details»
Arrivo Announces FDA Fast Track Designation for RABI-767 for …
Jul 15, 2024 For more information on Arrivo or RABI-767, please visit www.arrivobio.com. About Arrivo BioVentures LLC. Arrivo is propelled forward by its insatiable curiosity and drive to solve …See details»
Pipeline - ARRIVO Bioventures
RDU Center 3000 RDU Center Drive Suite 130 Morrisville, NC 27560-9731. 919.460.9500 phone 919.460.9509 fax. Email: [email protected]See details»
ArrivoBio: $45.25 Million Closed To Advance Treatments For Major ...
Dec 4, 2023 Arrivo BioVentures recently announced closing an oversubscribed Series B preferred financing round, totaling $45.25 million in committed capital, bringing the total raised …See details»
Major Depressive Disorder - ARRIVO Bioventures
RDU Center 3000 RDU Center Drive Suite 130 Morrisville, NC 27560-9731. 919.460.9500 phone 919.460.9509 fax. Email: [email protected]See details»